Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group

Hypertension (HTN) is frequently associated with the use of angiogenesis inhibitors targeting the vascular endothelial growth factor pathway and appears to be a generalized effect of this class of agent. We investigated the phenomenon in 61 patients with advanced hepatocellular carcinoma (HCC) recei...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Gardini, Andrea Casadei, Scarpi, Emanuela, Marisi, Giorgia, Foschi, Francesco Giuseppe, Donati, Gabriele, Giampalma, Emanuela, Faloppi, Luca, Scartozzi, Mario, Silvestris, Nicola, Bisulli, Marcello, Corbelli, Jody, Gardini, Andrea, Barba, Giuliano La, Veneroni, Luigi, Tamberi, Stefano, Cascinu, Stefano, Frassineti, Giovanni Luca
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Clinical Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924783/
https://ncbi.nlm.nih.gov/pubmed/26893366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7444
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki